(Q31997505)

5 July 2017

1 reference

title

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy (English)

1 reference

5 July 2017

0 references

0 references

Kegeles LS

1

1 reference

5 July 2017

Humaran TJ

series ordinal

2

1 reference

5 July 2017

Mann JJ

series ordinal

3

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

5 July 2017

Biological Psychiatry

1 reference

5 July 2017

44

1 reference

5 July 2017

6

1 reference

5 July 2017

382-398

1 reference

describes a project that uses

5 July 2017

1 reference

Mapping of metabolites in whole animals by 31P NMR using surface coils

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

A historical review of NMR and its clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

19F nuclear magnetic resonance spectroscopy of neuroleptics: the first in vivo pharmacokinetics of trifluoperazine in the rat brain and the first in vivo spectrum of fluphenazine in the human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Analysis of macromolecule resonances in 1H NMR spectra of human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Inositol trisphosphate and diacylglycerol as second messengers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Corpus callosum thickness in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

NMR chemical shift imaging in three dimensions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Magnetic resonance spectroscopy in schizophrenia: a nascent technology for a neurodevelopmental disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Non-invasive investigation of cerebral metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

The current status of the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Phospholipase A2: function and pharmacological regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Basal ganglia phosphorous metabolism in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Abnormal frontal lobe phosphorous metabolism in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Decreased temporal lobe phosphomonoesters in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Increased temporal lobe glucose use in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Noninvasive in vivo detection of a fluorinated neuroleptic in the human brain by 19F nuclear magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Cell loss in the hippocampus of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

NMR studies of intracellular metal ions in intact cells and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Regional Brain Function in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Spatially localized 1H NMR spectra of metabolites in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Observation of tissue metabolites using 31P nuclear magnetic resonance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

18Fluorodeoxyglucose PET in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Fluoxetine and trifluoperazine in human brain: a 19F-nuclear magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Phosphorus 31 Magnetic Resonance Spectroscopy Detects Altered Brain Metabolism Before Onset of Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Cerebrospinal fluid amino acid concentrations in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

In vivo magnetic resonance spectroscopy. Applications in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Detection of brain glutamate and glutamine in spectroscopic images at 4.1 T.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Studies on the function of N-acetyl aspartic acid in brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Phospholipid bilayer contribution to 31P NMR spectra in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Proton-decoupled 31P chemical shift imaging of the human brain in normal volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Resonance Absorption by Nuclear Magnetic Moments in a Solid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Clinical aspects on 31P NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Quantitative Brain Measurements in Chronic Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

1H-[13C] NMR measurements of [4-13C]glutamate turnover in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Nuclear magnetic resonance imaging and spectroscopy of human brain function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Determination of absolute phosphate metabolite concentrations in RIF-1 tumors in vivo by 31P-1H-2H NMR spectroscopy using water as an internal intensity reference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

The use of a priori knowledge to quantify short echo in vivo 1H MR spectra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

N-acetylaspartate in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Excitatory amino acid receptors in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

A technique for detecting GABA in the human brain with PRESS localization and optimized refocusing spectral editing radiofrequency pulses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900425-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(97)00425-3

1 reference

5 July 2017

1 reference